U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409168) titled 'Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL' on Feb. 06.
Brief Summary: This is a multicenter prospective study to develop and validate a multimodal, deep learning-based model for predicting treatment response in patients with extranodal natural killer/T-cell lymphoma (NKTCL) receiving first-line asparaginase-based therapy.
Study Start Date: Feb. 15
Study Type: OBSERVATIONAL
Condition:
Natural Killer/T-cell Lymphoma
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sun Yat-sen University
Information provided by (Responsible Party): Qingqing Cai, Sun Yat-sen University
Disclaimer: Curat...